Clinical Trials Logo

Clinical Trial Summary

To overcome unsuitable effects of controlled ovarian hyperstimulation (COH )while maintaining large oocyte availability, investigators elaborated an innovative protocol (NATural Ovarian Stimulation) that dissociates E2 production from multiple follicle development.

The purpose of this prospective, randomized trial is to demonstrate that, in a good prognosis IVF-ET population, the physiological E2 environment resulting from NATOS significantly improves IVF-ET outcome when compared to the conventional GnRH antagonist protocol.


Clinical Trial Description

Controlled ovarian hyperstimulation (COH) seeks to improve IVF-ET results by increasing per-cycle oocyte and embryo availability. Yet, the coexistence of multiple preovulatory follicles engenders compulsory alterations in the endocrine milieu of the follicular phase. The most evident of them are the extremely high serum estradiol (E2) levels. The 10 to 15-fold increase in E2 levels as a result of COH has been shown to provoke unwanted consequences in both embryo quality and uterine receptivity.

Therefore, investigators elaborated an innovative COH protocol (NATural Ovarian Stimulation) that aimed at dissociating E2 production from multiple follicle development. To obtain this effect, they virtually curtailed endogenous LH production by using GnRH antagonist doses as strong and frequent enough to maintain E2 levels around the physiological range during standard exogenous FSH-only administration. Given that high E2 levels are commonly reached in patients having a normal follicle endowment, NATOS should target this group of good prognosis IVF-ET candidates. Indeed, this new COH approach was first tested in a pilot study that included 15 good prognosis IVF-ET candidates, aged 25-35 years, who volunteered to undergo NATOS. 11 out of 15 patients achieved a pregnancy. These pilot results spurred them to conduct a prospective, randomized trial to demonstrate that, in a good prognosis IVF-ET population, the physiological E2 environment resulting from NATOS significantly improves IVF-ET outcome when compared to the conventional GnRH antagonist protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02892942
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Active, not recruiting
Phase Phase 4
Start date January 13, 2017
Completion date June 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03289403 - The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis Phase 2
Not yet recruiting NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Recruiting NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Recruiting NCT02868528 - A Study of Preimplantation Genetic Screening With Next Generation Sequencing Technology on Advanced Age Women N/A
Completed NCT00249834 - Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF) Phase 4
Not yet recruiting NCT03240302 - A Comparative Study of Sibling Oocytes: ICSI vs. the PICSI Sperm Selection Method N/A
Not yet recruiting NCT03240276 - A Comparative Study of Sibling Oocytes: ICSI vs. the IMSI Sperm Selection Method N/A
Recruiting NCT02942849 - Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Technology N/A
Recruiting NCT02912104 - A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Insufficiency Patients Phase 1
Recruiting NCT03105453 - The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)
Completed NCT02845388 - Sildenafil Citrate in Frozen Embryo Transfer Phase 2
Withdrawn NCT02549690 - Testosterone Gel in Poor Responders Undergoing IVF N/A
Not yet recruiting NCT02471677 - Corifollitropin Alfa Versus Follitropin Beta in High Responders Phase 4
Terminated NCT02712840 - Comparing Pregnancy Outcomes in Good Prognosis Patients Between Fresh and 'Freeze-All' Single Blastocyst Transfers N/A
Recruiting NCT02310919 - Administration of FSH and Low Dose hCG for Oocyte Maturity While Decreasing hCG Exposure in IVF Cycles Phase 3
Active, not recruiting NCT02268786 - Single Embryo TrAnsfeR of Euploid Embryo Phase 3
Terminated NCT02254928 - Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders Phase 4
Terminated NCT02246309 - Comparison Of The Embryoscope Time-Lapse System With Standard Embryo Culture N/A
Completed NCT02732808 - Dual Ovarian Stimulation in the Same IVF/ICSI Cycles for Treatment of Poor Ovarian Responders Phase 3
Recruiting NCT01977144 - Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency N/A